Replimune's shares crater as FDA rejects melanoma drug

fiercebiotech.com/biotech/replimunes-request-melanoma-approval-rejected-fda-cratering-stock

This story appeared on fiercebiotech.com, 2025-07-22 18:17:41.274000.
The Entire Business World on a Single Page. Free to Use →